These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 16102988)

  • 21. Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials.
    Ricotti V; Evans MR; Sinclair CD; Butler JW; Ridout DA; Hogrel JY; Emira A; Morrow JM; Reilly MM; Hanna MG; Janiczek RL; Matthews PM; Yousry TA; Muntoni F; Thornton JS
    PLoS One; 2016; 11(9):e0162542. PubMed ID: 27649492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between foot strength and motor function in preschool-age children.
    Rose KJ; Burns J; North KN
    Neuromuscul Disord; 2009 Feb; 19(2):104-7. PubMed ID: 19056267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of deflazacort on cardiac and sternocleidomastoid muscles in Duchenne muscular dystrophy: a magnetic resonance imaging study.
    Mavrogeni S; Papavasiliou A; Douskou M; Kolovou G; Papadopoulou E; Cokkinos DV
    Eur J Paediatr Neurol; 2009 Jan; 13(1):34-40. PubMed ID: 18406648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy.
    Mazzone E; Martinelli D; Berardinelli A; Messina S; D'Amico A; Vasco G; Main M; Doglio L; Politano L; Cavallaro F; Frosini S; Bello L; Carlesi A; Bonetti AM; Zucchini E; De Sanctis R; Scutifero M; Bianco F; Rossi F; Motta MC; Sacco A; Donati MA; Mongini T; Pini A; Battini R; Pegoraro E; Pane M; Pasquini E; Bruno C; Vita G; de Waure C; Bertini E; Mercuri E
    Neuromuscul Disord; 2010 Nov; 20(11):712-6. PubMed ID: 20634072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reductions in functional muscle mass and ability to ambulate in Duchenne muscular dystrophy from ages 4 to 24 years.
    Evans WJ; Hellerstein M; Butterfield RJ; Smith E; Guglieri M; Katz N; Nave B; Branigan L; Thera S; Vordos KL; Behar L; Schiava M; James MK; Field T; Mohammed H; Shankaran M
    J Physiol; 2024 Oct; 602(19):4929-4939. PubMed ID: 39216089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A method to evaluate contractures effects during the gait of children with Duchenne dystrophy.
    Gaudreault N; Gravel D; Nadeau S; Desjardins P; Brière A
    Clin Orthop Relat Res; 2007 Mar; 456():51-7. PubMed ID: 17195816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early prednisone treatment in Duchenne muscular dystrophy.
    Merlini L; Cicognani A; Malaspina E; Gennari M; Gnudi S; Talim B; Franzoni E
    Muscle Nerve; 2003 Feb; 27(2):222-7. PubMed ID: 12548530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation.
    Desguerre I; Mayer M; Leturcq F; Barbet JP; Gherardi RK; Christov C
    J Neuropathol Exp Neurol; 2009 Jul; 68(7):762-73. PubMed ID: 19535995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial.
    Nagy S; Hafner P; Schmidt S; Rubino-Nacht D; Schädelin S; Bieri O; Fischer D
    Trials; 2019 Nov; 20(1):637. PubMed ID: 31752977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscle metabolism in Duchenne muscular dystrophy assessed by in vivo proton magnetic resonance spectroscopy.
    Hsieh TJ; Jaw TS; Chuang HY; Jong YJ; Liu GC; Li CW
    J Comput Assist Tomogr; 2009; 33(1):150-4. PubMed ID: 19188804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of long-term steroids on cough efficiency and respiratory muscle strength in patients with Duchenne muscular dystrophy.
    Daftary AS; Crisanti M; Kalra M; Wong B; Amin R
    Pediatrics; 2007 Feb; 119(2):e320-4. PubMed ID: 17272595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial.
    Hafner P; Bonati U; Rubino D; Gocheva V; Zumbrunn T; Gueven N; Fischer D
    Trials; 2016 Aug; 17(1):389. PubMed ID: 27488051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of regional body composition with dual-energy X-ray absorptiometry in Duchenne muscular dystrophy: correlation of regional lean mass and quantitative strength.
    Skalsky AJ; Han JJ; Abresch RT; Shin CS; McDonald CM
    Muscle Nerve; 2009 May; 39(5):647-51. PubMed ID: 19347922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Standing balance in healthy boys and in children with Duchenne muscular dystrophy.
    Kelly CR; Redford JB; Zilber S; Madden PA
    Arch Phys Med Rehabil; 1981 Jul; 62(7):324-7. PubMed ID: 7247659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials.
    Alfano LN; Miller NF; Berry KM; Yin H; Rolf KE; Flanigan KM; Mendell JR; Lowes LP
    Neuromuscul Disord; 2017 May; 27(5):452-457. PubMed ID: 28279570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valley sign in duchenne muscular dystrophy: importance in patients with inconspicuous calves.
    Pradhan S
    Neurol India; 2002 Jun; 50(2):184-6. PubMed ID: 12134184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upper extremity functional assessment scales in children with Duchenne muscular dystrophy: a comparison.
    Hiller LB; Wade CK
    Arch Phys Med Rehabil; 1992 Jun; 73(6):527-34. PubMed ID: 1622300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profoundly lower muscle mass and rate of contractile protein synthesis in boys with Duchenne muscular dystrophy.
    Evans WJ; Shankaran M; Smith EC; Morris C; Nyangau E; Bizieff A; Matthews M; Mohamed H; Hellerstein M
    J Physiol; 2021 Dec; 599(23):5215-5227. PubMed ID: 34569076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of non-invasive ventilation on respiratory muscle loading and endurance in patients with Duchenne muscular dystrophy.
    Toussaint M; Soudon P; Kinnear W
    Thorax; 2008 May; 63(5):430-4. PubMed ID: 18057095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of skeletal muscle mass in Duchenne muscular dystrophy: use of 24-h creatinine excretion.
    Franciotta D; Zanardi MC; Albertotti L; Orcesi S; Berardinelli A; Pichiecchio A; Uggetti C; Tagliabue A
    Acta Diabetol; 2003 Oct; 40 Suppl 1():S290-2. PubMed ID: 14618496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.